spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Trump announces Pfizer price cuts as White House presses drugmakers

President Donald Trump on Tuesday said Pfizer (PFE.N), opens new tab will cut the price on all of its prescription drugs sold to the Medicaid insurance program and will introduce all new prescription drugs at a “most favored nation” price.

The White House is also planning to unveil a direct-to-consumer website for Americans to buy drugs, called TrumpRx, the official added. Pfizer will launch sales of some of its drugs directly to consumers through that website.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Trump sent letters to 17 leading drug companies in July telling them to slash drug prices to match those paid overseas – a policy the president has called most favored nation pricing. He asked them to respond with binding commitments by September 29.

Pfizer is the first company to announce a deal. A company spokesperson was not immediately available for comment.

The U.S. has been engaged in one-on-one talks with the companies, Health Secretary Robert F. Kennedy Jr. said at a cabinet meeting last month, adding that Commerce Secretary Howard Lutnick was using the threat of tariffs on the industry for additional leverage.

Hot this week

Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation

Daewoong Pharmaceutical said on October 17 that it met...

Novo Nordisk chair and independent directors to exit in strategy dispute

The chair of Wegovy maker Novo Nordisk and six...

Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG

Medical diagnostics firm Hologic has agreed to be acquired...

China’s Innovent signs $11.4 billion cancer therapy deal with Japan’s Takeda

-China’s Innovent Biologics said on Wednesday it had signed...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img